NHP — Lumiera Health Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Lumiera Health, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2021 November 30th | 2022 November 30th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | fx Final | Final |
| Revenue | ||
| Total Revenue | 0.429 | 0.631 |
| Cost of Revenue | ||
| Gross Profit | 0.214 | 0.144 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 1.75 | 2.81 |
| Operating Profit | -1.32 | -2.18 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.96 | -2.77 |
| Net Income After Taxes | -0.96 | -2.77 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.96 | -2.77 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.96 | -2.77 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.011 | -0.012 |